Khaled, Y., Varela, J., Khaled, S., Hatton, R., Smith, M., Deygoo, S., Nguyen, A., Nguyen, H. L., Adams, C. B. (2025). Reduced dose post-transplant cytoxan (Intermediate -Dose) in combination with abatacept after matched unrelated donor transplant for high -risk hematological malignancy may reduce treatment related mortality and risk of relapse.. Blood. https://doi.org/10.1182/blood-2025-4196